ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1350 National Cancer Institute Html en Adult Central Nervous System Tumors Treatment (PDQ®)–Patient Version Expert-reviewed information summary about the treatment of adult central nervous system tumors.
treatment0.515559
malignant tumor cells0.227722
general information0.262069
NCI-supported cancer0.222651
cancer cells0.27674
type0.244277
spinal cord tumors0.473603
clinical trial search0.391071
brain tumors0.2801
spinal cord0.914442
tumor cells0.493038
normal cells0.296092
clinical trial0.432056
clinical trials0.701078
brain tumor0.235359
brain0.738045
PDQ summary0.285532
tumors0.535252
cancer clinical trials0.361596
tumor0.77091
radiation therapy0.479169
grade0.218633
cancer0.578346
information0.296506
CLICK HERE
1385 National Cancer Institute Html en Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Prevention (PDQ®)–Health Professional Version Expert-reviewed information summary about factors that may influence the risk of developing ovarian, fallopian tube, and primary peritoneal cancers and about research aimed at the prevention of them.
oral contraceptives0.660699
untreated subfertile women0.554695
population-based case-control study0.569591
multiple case-control studies0.577558
tubal ligation0.612813
ovarian cancer subtypes0.638647
endometrioid carcinomas0.557685
Ovarian Cancer Association0.647707
invasive ovarian tumors0.625952
tubal intraepithelial carcinoma0.613375
case-control studies0.724549
modest increased risk0.571056
ovarian cancer0.933826
clear cell carcinomas0.577194
oral contraceptive therapy0.556361
ovarian carcinoma0.65109
ovarian reserve0.599754
ovarian borderline tumor0.646023
low-grade ovarian carcinomas.0.649208
ovarian primary tumors.0.639278
high-grade carcinomas0.568553
cohort studies0.697042
hospital-based case-control studies0.582441
ovarian cancer cases0.640486
epithelial ovarian cancers0.62928
women0.680224
borderline ovarian tumors0.627194
prospective cohort studies0.573074
risk reduction0.631051
cohort study0.558817
ovarian carcinomas0.707015
clear cell cancer0.56063
ovarian cancers0.642329
unexposed infertile women0.555673
observed risk reduction0.618238
ovarian hyperstimulation0.617463
significant increased risk0.567639
high-grade serous carcinomas0.73533
fallopian tube0.554218
epithelial ovarian cancer0.644523
ovarian cancer risk0.740549
epidemiological studies0.565
population-based case-control studies0.621559
gastrointestinal primary tumors0.557125
Netherlands cohort study0.55691
ovarian carcinoma subtypes0.642907
meta-analysis0.563338
systematic review0.583056
CLICK HERE
1754 National Cancer Institute Html en Breast Reconstruction After Mastectomy A fact sheet that describes breast reconstruction after mastectomy, including surgical options, follow-up care, and breast cancer screening after reconstruction.
breast reduction surgery0.28849
tissue breast reconstruction0.452019
flap reconstruction0.330223
immediate reconstruction0.31662
tissue0.60196
breast reconstruction surgery0.457163
mastectomy0.359177
implant0.307847
implant reconstruction0.254395
breast numbness0.249047
donor tissue0.258639
breast skin0.288491
early-stage breast cancer0.279638
natural breast shape0.273514
pedicled flap reconstruction0.298564
autologous tissue reconstruction0.366797
breast cancer experience0.279508
reconstructed breast0.419512
autologous reconstruction0.246473
tissue expander0.25279
blood vessels0.426971
chest wall tissue0.239092
entire breast0.302278
Delayed reconstruction0.247408
breast cancer therapy0.323533
radiation therapy0.283075
breast reconstruction technique0.360333
breast forms0.256638
external breast prostheses0.334034
women0.280496
surgical nipple reconstruction0.280177
breast reconstruction method0.374498
breast reconstruction0.909174
breast rebuilt0.281588
free flap reconstruction0.325097
breast cancer recurrence0.30156
woman considering breast0.279422
breast tissue0.318522
flap0.344123
sufficient breast volume0.289888
autologous tissue0.583784
Breast Implants page0.303495
breast surgeons0.246995
breast area0.280597
breast cancer0.510147
skin-sparing mastectomy0.235094
Breast Disease0.251106
inflammatory breast cancer0.289892
chest tissue0.237416
CLICK HERE
1786 National Cancer Institute Html es Linfedema (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento del linfedema.
siguientes áreas0.436931
causa hinchazón0.778344
pequeña cantidad0.464081
pequeños cortes0.452311
siguientes abordajes0.459419
PDQ Linfedema0.618416
sección información0.436578
largo plazo0.580542
protector solar0.453778
sección manejo0.432902
National Cancer Institute0.432858
ropa flojos0.450402
siguientes riesgos0.424859
Instituto Nacional0.463187
siguientes problemas0.490486
linfedema atrapa0.967072
Physician Data Query0.535003
Estados Unidos0.442188
estadio iii0.728645
siguientes medidas0.469803
linfa circula0.531655
linfedema.ampliar anatomía0.480452
siguientes pruebas0.475048
uñas ayuda0.454713
baja potencia0.433231
CLICK HERE
1840 National Cancer Institute Html es Tratamiento de la enfermedad trofoblástica de la gestación (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento de la enfermedad trofoblástica de la gestación.
Obstet Gynecol0.314049
calificación pronóstica0.330592
Agarwal R0.309981
gestational trophoblastic tumor0.470216
gynecologic oncology0.31949
gestational trophoblastic tumour0.330225
Sin embargo0.495025
largo plazo0.308011
drug-resistant gestational trophoblastic0.316646
trophoblastic tumor simulating0.31025
gestational trophoblastic0.969098
high-risk gestational trophoblastic0.417868
site trophoblastic tumor0.331006
Epithelioid trophoblastic tumor0.331525
oncology group study0.309029
retrospective observational study0.310708
trophoblastic neoplasia with0.311489
trophoblastic tumor0.525373
newlands es0.321142
gestational trophoblastic neoplasia0.524164
Gynecol Oncol0.321149
Database Syst Rev0.308864
placental site trophoblastic0.326491
chemorefractory gestational trophoblastic0.316598
Reprod Med0.395131
gynecologic oncology group0.309183
Lancet Oncol0.308542
Organización Mundial0.310432
tumores trofoblásticos epitelioides0.326002
Lurain JR0.332449
metastatic gestational trophoblastic0.30963
Holden L0.308229
Cancer Staging Manual0.311272
Féderation Internationale0.320433
trophoblastic disease0.450228
with gestational trophoblastic0.311191
trophoblastic tumours0.335737
Recurrent gestational trophoblastic0.309132
Clin Oncol0.324887
sistema nervioso central0.319546
low-risk gestational trophoblastic0.340233
Charing Cross0.316962
Gynaecol Obstet0.314146
persistent gestational trophoblastic0.309878
Short D0.308931
FIGO Committee0.309443
Charing Cross Hospital0.309844
Obstet Gynaecol0.310271
AJCC Cancer Staging0.31188
CLICK HERE
2023 National Cancer Institute Html es Prevención del cáncer de seno (mama) (PDQ®)–Versión para pacientes Sumario de información revisada por expertos sobre factores que influyen en el riesgo de presentar cáncer de mama y sobre las investigaciones dirigidas a la prevención de esta enfermedad.
Risk Assessment Tool0.639814
enfermedad benigna0.724402
voluntarios sanos0.550874
siguientes afecciones0.583572
posibles daños0.559702
vía oral0.551992
largo plazo0.555083
carcinoma lobulillar situ0.643038
National Cancer Institute0.566999
vitamina a0.552574
siguientes riesgos0.550628
Instituto Nacional0.618668
protección ayuda0.699167
Physician Data Query0.746401
Estados Unidos0.579171
suficiente ejercicio0.906195
siguientes características0.59401
prevención revisa0.554009
PDQ Prevención0.599371
Menor exposición0.569365
siguientes formas0.705774
pequeñas llamadas lobulillos0.645602
Mayor edad0.567138
genes brca10.883252
conductos.ampliar anatomía0.589939
siguientes sumarios0.661886
CLICK HERE
3424 National Cancer Institute Html es Informes de patología Hoja informativa que describe el tipo de información que puede aparecer en un informe de patología, el cual contiene los resultados de la examinación visual y microscópica del tejido extirpado durante una biopsia o cirugía.
página del nci0.749066
cromosoma filadelfia0.760969
¿Cuánto tiempo0.803391
leucemia mielógena0.766464
tipo southern0.748591
Detecta fragmentos0.751768
simple vista0.960274
Instituto Nacional0.833257
cuello uterino0.83163
CLICK HERE
15650 National Cancer Institute Html en Step 2: Application Receipt & Assignment Information on the assignment numbers the Center for Scientific Review (CSR) creates once an application is submitted and other submission policies.
Application Type0.237536
100,228th application0.228911
program director0.554123
peer review process0.902016
initial peer review0.326681
Scientific Review0.216004
new application0.239088
specific application0.226573
Resubmission Applications0.206964
research grant applications0.359218
his/her assigned application0.489157
specific budgetary limits0.31822
Program Announcements0.201839
pre-announced Request0.201939
appropriate application form0.353459
new grant0.218872
NIH peer review0.369648
Incomplete applications0.208003
NCI program director0.428336
suffix code0.378185
grant numbers0.228139
application0.702093
NIH Policy0.353037
traditional research project0.330544
central receipt point0.406816
CLICK HERE
16822 National Cancer Institute Html es Essiac y Flor Essence (PDQ®)–Versión para pacientes Resumen de información revisada por expertos sobre el uso de Essiac o Flor Essence como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.
Centro Nacional0.301601
New Hampshire Avenue0.301144
Drug Administration0.30071
Flor Essence0.987323
NCI Best Case0.302063
modelos animales0.300855
Indiana University-Purdue University0.301652
datos bibliográficos pubmed0.301216
siguientes preguntas0.300694
productos essiac0.309556
modelo animal0.300781
PDQ Essiac0.318217
National Cancer Institute0.301364
Royal Cancer Commission0.301752
Olmo resbaladizo0.301149
siguientes riesgos0.300858
Instituto Nacional0.309533
Salud Complementaria0.302607
Visuals Online0.300813
complementarias revisa0.30115
Physician Data Query0.304689
Sloan Kettering Cancer0.301678
Estados Unidos0.332086
siguientes estudios0.301314
libre uso0.301062
distintos resultados0.300776
únicos efectos0.301309
ratón p3880.301025
página manejo0.300756
¿El tratamiento0.301379
Nueva York0.300871
¿Los beneficios0.30071
juntos cam0.300681
Series Program0.300695
medicina complementaria0.332457
CLICK HERE
16830 National Cancer Institute Html en Clinical Trial Sequencing Project null
gene expression test0.968523
vital genomic information0.445867
non-metastatic RCC0.377128
breast cancer response0.478667
Large B Cell0.384272
NCTN clinical trials0.448807
ECOG-ACRIN E2805 trial0.421922
DLBCL patients0.352651
National Clinical Trials0.46574
molecular basis0.431838
advanced RCC0.374566
clinical trials0.533121
VEGF inhibitors0.375945
clinical trial0.642586
RCC development0.370697
breast cancer patients0.519364
comprehensive molecular analysis0.404401
Genomic Data Commons0.460933
Trial Assigning Individualized0.463121
cancer types0.360865
surgical removal0.412464
chemotherapy best complements0.471441
large B-cell lymphoma0.45172
cancer recurrence0.405985
low-risk patients0.363667
clinically helpful tool0.4004
rich molecular data0.400698
Combination Chemotherapy0.375651
cancer research community0.644574
adult non-Hodgkin lymphoma0.414301
Her2-negative breast cancer0.645596
NCI-sponsored clinical trial0.620071
common kidney cancer0.437411
endothelial growth factor0.403689
different chemotherapy regimens0.474741
human epidermal growth0.418539
anonymized clinical data0.446701
genomic alterations0.360205
CCG0.375478
NCI-sponsored clinical trials0.472546
pathway drives RCC0.461359
breast cancer0.780189
best individualized treatment0.43596
Clinical Trial Sequencing0.508554
tissue samples0.518757
breast cancer treatments0.478341
renal cell carcinoma0.625007
New England Journal0.405702
Diffuse Large0.405055
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.